Trial Profile
A phase I study of ladostigil in patients with mild cognitive impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Ladostigil (Primary)
- Indications Mild cognitive impairment
- Focus Adverse reactions
- 29 Jul 2015 New trial record